Two Sigma Securities’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Two Sigma Securities’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-874	Closed	-$4.58K	–	3743
2023 Q3	$4.58K	Sell	874 -75	-8%	-$466	﹤0.01%	2794
2023 Q2	$6.69K	Buy	+949	New	+$8.18K	﹤0.01%	2642

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Securities's NEXI Position: Q4 2023 in Review

Two Sigma Securities sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 874 shares — an estimated $4.58K sold.

Two Sigma Securities first reported a position in NEXI in Q2 2023 and held it in 2 quarters. The position peaked at $6.69K in Q2 2023. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Two Sigma Securities reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Two Sigma Securities sold 874 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $4.58K.
Two Sigma Securities first reported a position in NexImmune, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Two Sigma Securities's NexImmune, Inc. Common Stock position peaked at $6.69K in Q2 2023.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.